Business Context and Reporting Period
This Form 8-K filing by Rexahn Pharmaceuticals, Inc. (not Opus Genetics, Inc.) reports on the results of the Annual Meeting of Shareholders held on June 6, 2011. The report was filed on June 10, 2011, pursuant to Item 5.07 regarding the submission of matters to a vote of security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused exclusively on corporate governance voting results and does not contain financial statements.
Material Changes and Voting Results
The filing details the outcomes of four shareholder proposals:
- Proposal 1 (Election of Directors): All seven nominees were elected. Voting results showed strong support, with approximately 48.2 million votes "For" each director against roughly 1.2 to 1.3 million votes "Against." There were 24,159,971 broker non-votes.
- Proposal 2 (Independent Auditor): Shareholders approved the selection of ParenteBeard LLC as the independent auditor for the year ending December 31, 2011. Results: 72,179,701 For, 819,704 Against, 2,631,152 Abstain.
- Proposal 3 (Advisory Vote on Executive Compensation): The "Say-on-Pay" proposal was approved. Results: 48,214,957 For, 961,191 Against, 2,294,439 Abstain. There were 24,159,971 broker non-votes.
- Proposal 4 (Frequency of Say-on-Pay): Shareholders approved holding future advisory votes on executive compensation every three years. Results: 36,537,680 votes for 3 years, 10,341,290 for 1 year, 2,413,038 for 2 years, and 2,178,578 Abstain. There were 24,159,971 broker non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of voting tallies.
Important Facts for Investors to Verify
- Confirm the company name is Rexahn Pharmaceuticals, Inc., as the input metadata incorrectly referenced Opus Genetics, Inc.
- Verify the significant number of broker non-votes (24,159,971) on Proposals 1, 3, and 4, which indicates a large portion of shares held by brokers were not voted on these specific matters.
- Note the approval of ParenteBeard LLC as the independent auditor for the 2011 fiscal year.
- Observe that shareholders selected a three-year frequency for future executive compensation advisory votes.